Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by GunnerGon Dec 31, 2019 10:06am
32 Views
Post# 30504813

RE:RE:Quick question

RE:RE:Quick questionKnow nothing pumper; can't even spell the product name correctly. 

Nor does he know how to calculate %gain.

Six or so pumpers on this BB you don't want to take advice from.  Pando, Newcamo, Realstocky, moneyman.....all the same person making same goofing predictions, spelling mistakes and incorrect math calculations.

Company let go production staff and top researchers in Nov/Dec 2019.  Has been trying to implement FDA requested production changes for two years for Ryplazim.  4050 has been trying to get FDA to nail down phase 3 for over a year.

Company president, at Nov Stifel Conf, stated partnership for Ryp wouldn't be until after Ryp approved in US and Europe.




realstocky wrote:
h1 first 6 months and h2 last 6 months...but per last presentation on operations, riplazym deal is coming earlier... then we had the crazy day last wedneday where the sp tripled... so stay tuned


<< Previous
Bullboard Posts
Next >>